无症状的肺纤维化与肺动脉的ipsilateral近端中断 (PIPA) 相关
1Radiology, Brooke Army Medical Center, San Antonio, USA.
Cureus
|November 28, 2024
概括
本病例报告详细介绍了一例罕见的单侧肺纤维化病例,该病例发生在一名33岁的男性身上,该病例与肺动脉单侧近端中断 (PIPA) 相关. 这些发现强调了罕见的肺部疾病的诊断挑战.
科学领域:
- 肺部病理学 肺部病理学
- 放射学 放射学是一门学科.
- 心血管医学 心血管医学
背景情况:
- 单侧肺纤维化很少见,通常与炎症原因有关.
- 肺动脉单侧近端中断 (PIPA) 是一种罕见的先天性异常.
- 关于与PIPA同时发生的肺纤维化存在有限的文献.
研究的目的:
- 为了呈现与PIPA相关的单边肺纤维化病例.
- 突出罕见单边肺部疾病的诊断复杂性.
主要方法:
- 一个33岁的男性患有慢性喘,肩部疼痛的病例报告.
- 最初的胸部X射线图显示了右肺的不透明度和体积损失.
- 胸部计算机断层扫描 (CT) 和CT血管图证实了右侧肺纤维化和右肺动脉缺失.
主要成果:
- 患者表现出右侧肺纤维化和肺动脉的单侧近端中断.
- 没有发现其他显著的心肺异常.
- 放射和CT发现对于诊断至关重要.
结论:
- 这一案例强调了与PIPA同时存在的单边肺纤维化病的罕见性.
- 这种罕见疾病的有效诊断和管理需要先进的成像和临床相关性.
相关概念视频
Pneumonia I: Introduction
211
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
150
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
150
Pneumothorax-I
170
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
170
Pulmonary Hypertension: Classification and Pathogenesis
150
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
150
Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174
Phosphoinositides and PIPs
8.4K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.4K


